Mega Lifesciences Public Company Limited (MEGA-R.BK)
THB 32.75
(0.0%)
THB 32.75
(0.0%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 1.96 Billion | 1.99 Billion | 2.72 Billion | 1.62 Billion | 1.49 Billion | 919.35 Million |
| Net Income | 1.99 Billion | 2.24 Billion | 1.94 Billion | 1.38 Billion | 1.13 Billion | 1.2 Billion |
| Depreciation & Amortization | 285.87 Million | 272.01 Million | 274.43 Million | 256.33 Million | 159.9 Million | 147.77 Million |
| Deferred income taxes | 269.05 Million | 354.63 Million | 336.02 Million | 234.32 Million | 160.02 Million | 202.75 Million |
| Stock-based compensation | - | - | - | - | - | 9.97 Million |
| Change in working capital | -590.21 Million | -593.09 Million | 444.54 Million | -170.35 Million | 20.94 Million | -330.17 Million |
| Other non-cash items | 1.48 Billion | -276.97 Million | 20.39 Million | 64.33 Million | 63.86 Million | -317.03 Million |
| Investing Cash Flow | -309.15 Million | -280.82 Million | -264.68 Million | -650.28 Million | -172.46 Million | -647.21 Million |
| Investments in PPE | -293.57 Million | -312.74 Million | -159.77 Million | -255.06 Million | -540.81 Million | -751.89 Million |
| Acquisitions | 4.52 Million | -9.25 Million | 8.37 Million | -405.98 Million | -13.21 Million | -257.82 Million |
| Investment purchases | -355.52 Million | -335.41 Million | -333.66 Million | -211.09 Million | 12.3 Million | -574.47 Million |
| Sales/Maturities of investments | 335.41 Million | 333.66 Million | 211.09 Million | 207.14 Million | 367.33 Million | 696.5 Million |
| Other Investing Activities | 24.63 Million | 42.92 Million | 9.28 Million | 14.71 Million | 1.92 Million | 240.47 Million |
| Financing Cash Flow | -1.67 Billion | -1.43 Billion | -1.31 Billion | -1.22 Billion | -621.3 Million | -176.96 Million |
| Debt repayment | -148.66 Million | -58.1 Million | -363 Million | -487.56 Million | -1.15 Million | -5.72 Million |
| Dividends payments | -1.43 Billion | -1.4 Billion | -922.94 Million | -670.19 Million | -618.1 Million | -614.5 Million |
| Common Stock Repurchased | - | - | - | - | -114.43 Million | -26.59 Million |
| Common Stock Issuance | - | - | - | - | 114.43 Million | 37.22 Million |
| Other Financing Activities | -88.6 Million | 30.43 Million | -27.93 Million | -64.63 Million | -2.04 Million | 443.27 Million |
| Accounts receivables | -323.89 Million | -631.47 Million | 18.01 Million | 68.51 Million | -146.82 Million | -9.91 Million |
| Accounts payables | -885.26 Million | 364.68 Million | 375.67 Million | 48.43 Million | 369.21 Million | 80.21 Million |
| Inventory | 569.37 Million | -399.94 Million | -330.24 Million | -603.09 Million | -334.75 Million | -377.06 Million |
| Other working capital | 49.57 Million | 73.64 Million | 381.08 Million | 315.79 Million | 133.3 Million | -23.4 Million |
| Cash at beginning of period | 2.45 Billion | 2.19 Billion | 1 Billion | 1.24 Billion | 559.53 Million | 477.67 Million |
| Cash at end of period | 2.36 Billion | 2.45 Billion | 2.19 Billion | 1 Billion | 1.24 Billion | 559.53 Million |
| Capital Expenditure | -293.57 Million | -312.74 Million | -159.77 Million | -255.06 Million | -540.81 Million | -751.89 Million |
| Effect of forex changes on cash | -64.92 Million | -26.76 Million | 42.98 Million | 1.76 Million | -12.93 Million | -13.31 Million |
| Net cash flow / Change in cash | -91.91 Million | 255.77 Million | 1.19 Billion | -241.47 Million | 688.39 Million | 81.86 Million |
| Free Cash Flow | 1.66 Billion | 1.68 Billion | 2.56 Billion | 1.37 Billion | 954.28 Million | 167.46 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 512.81 Million | 477.64 Million | 1.99 Billion | 473.18 Million | 535.43 Million | 530.92 Million |
| Depreciation & Amortization | 70.91 Million | 69.4 Million | 285.87 Million | 73.13 Million | 72.45 Million | 70.94 Million |
| Deferred income taxes | 29.42 Million | -29.42 Million | 269.05 Million | 58.39 Million | 97.62 Million | 40.08 Million |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | 412 Million | -134.51 Million | -590.21 Million | -309.24 Million | 143.47 Million | -46.92 Million |
| Other non-cash items | -68.52 Million | -120.3 Million | 1.48 Billion | 210.81 Million | -29.1 Million | 46.5 Million |
| Investing Cash Flow | 293.14 Million | -28.18 Million | -309.15 Million | -94.12 Million | -70.18 Million | -36.88 Million |
| Investments in PPE | -63.29 Million | -37.89 Million | -293.57 Million | -77.09 Million | -88.42 Million | -46.92 Million |
| Acquisitions | 15.56 Million | 563 Thousand | 4.52 Million | 1.54 Million | 568 Thousand | 325 Thousand |
| Investment purchases | 340.67 Million | -347.11 Million | -355.52 Million | -18.56 Million | -1000.00 | 1000.00 |
| Sales/Maturities of investments | 207 Thousand | 356.25 Million | 335.41 Million | 1.03 Million | -568 Thousand | -325 Thousand |
| Other Investing Activities | 367.49 Million | 26.07 Million | 24.63 Million | -1.03 Million | 18.23 Million | 10.04 Million |
| Financing Cash Flow | -627.3 Million | -2.42 Million | -1.67 Billion | -2.58 Million | -920.22 Million | -754.16 Million |
| Debt repayment | -84.98 Million | -13.46 Million | -148.66 Million | -10.23 Million | -16.5 Million | -45.6 Million |
| Dividends payments | -697.43 Million | -14 Thousand | -1.43 Billion | -891 Thousand | -697.23 Million | -741.14 Million |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -14.85 Million | 8.6 Million | -88.6 Million | 8.54 Million | -206.48 Million | 32.58 Million |
| Accounts receivables | -135.52 Million | 390.9 Million | -323.89 Million | 91.22 Million | -161.11 Million | -186.7 Million |
| Accounts payables | 542.99 Million | -234.35 Million | -885.26 Million | -447.19 Million | -277.29 Million | 208.71 Million |
| Inventory | -163.8 Million | 282.22 Million | 569.37 Million | 445.62 Million | 11.35 Million | 113.88 Million |
| Other working capital | 168.32 Million | -573.29 Million | 49.57 Million | -398.88 Million | 570.53 Million | -182.81 Million |
| Cash at beginning of period | 2.97 Billion | 2.36 Billion | 2.45 Billion | 2.11 Billion | 2.41 Billion | 2.65 Billion |
| Cash at end of period | 3.69 Billion | 2.97 Billion | 2.36 Billion | 2.36 Billion | 2.11 Billion | 2.41 Billion |
| Capital Expenditure | -63.29 Million | -37.89 Million | -293.57 Million | -77.09 Million | -88.42 Million | -46.92 Million |
| Effect of forex changes on cash | -3.68 Million | 79.3 Million | -64.92 Million | -42.95 Million | -5.78 Million | -3.65 Million |
| Net cash flow / Change in cash | 720.44 Million | 611.86 Million | -91.91 Million | 247.11 Million | -299.48 Million | -241.36 Million |
| Free Cash Flow | 995.18 Million | 524.88 Million | 1.66 Billion | 314.17 Million | 608.29 Million | 506.4 Million |
FCCT
3898
3346
BBU-UN
GTRIF
VLTAF